Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A22825 | 24282628 | Oxid Med Cell Longev | Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. | 2013 | Details |
| A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
| A22827 | 24280139 | Folia Biol (Praha) | Histological evaluation of the role of atypical antipsychotic drugs in inducing non-alcoholic fatty liver disease in adult male albino rats (light and electron microscopic study). | 2013 | Details |
| A22828 | 24277674 | Curr Diab Rep | Nonalcoholic fatty liver disease and type 2 diabetes in obese children. | 2014 | Details |
| A22829 | 24277052 | J Gastroenterol | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. | 2013 | Details |
| A22830 | 24275855 | Curr Opin Oncol | Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer. | 2014 | Details |
| A22831 | 24275711 | J Clin Gastroenterol | The prevalence of elevated alanine transaminase and its possible causes in the general Korean population. | 2014 | Details |
| A22832 | 24275555 | Biochim Biophys Acta | Peri-conceptional obesogenic exposure induces sex-specific programming of disease susceptibilities in adult mouse offspring. | 2013 | Details |
| A22833 | 24275089 | Food Chem Toxicol | Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. | 2013 | Details |
| A22834 | 24275070 | Toxicol Appl Pharmacol | Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats. | 2013 | Details |
| A22836 | 24274878 | Clin Liver Dis | Host genetic variants in obesity-related nonalcoholic fatty liver disease. | 2013 | Details |
| A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
| A22838 | 24274876 | Clin Liver Dis | Obesity, nutrition, and liver disease in children. | 2014 | Details |
| A22839 | 24274875 | Clin Liver Dis | Impact of nutrition and obesity on chronic liver disease. | 2013 | Details |
| A22840 | 24274874 | Clin Liver Dis | Obesity and liver cancer. | 2013 | Details |
| A22841 | 24274872 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. | 2014 | Details |
| A22842 | 24274870 | Clin Liver Dis | The impact of obesity and metabolic syndrome on chronic hepatitis C. | 2013 | Details |
| A22843 | 24274869 | Clin Liver Dis | Surgical management of obesity in patients with morbid obesity and nonalcoholic fatty liver disease. | 2013 | Details |
| A22844 | 24274868 | Clin Liver Dis | Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A22845 | 24274867 | Clin Liver Dis | The role of diet and nutritional intervention for the management of patients with NAFLD. | 2013 | Details |
| A22846 | 24274866 | Clin Liver Dis | The role of medications for the management of patients with NAFLD. | 2013 | Details |
| A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
| A22848 | 24274863 | Clin Liver Dis | The impact of obesity on liver histology. | 2013 | Details |
| A22849 | 24274862 | Clin Liver Dis | Obesity-associated nonalcoholic fatty liver disease. | 2013 | Details |
| A22850 | 24274861 | Clin Liver Dis | Obesity and liver disease: the epidemic of the twenty-first century. | 2014 | Details |
| A22851 | 24273892 | Pharmazie | Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs. | 2013 | Details |
| A22852 | 24251711 | J Gastroenterol Hepatol | Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan. | 2013 | Details |
| A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
| A22854 | 24251709 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22855 | 24251708 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease: factors associated with its presence and onset. | 2013 | Details |
| A22856 | 24251707 | J Gastroenterol Hepatol | Characteristics and diagnosis of NAFLD/NASH. | 2013 | Details |
| A22857 | 24251706 | J Gastroenterol Hepatol | Diet and exercise in management of obesity and overweight. | 2013 | Details |
| A22858 | 24251704 | J Gastroenterol Hepatol | Obesity and gastrointestinal liver disorders in Japan. | 2013 | Details |
| A22859 | 24251697 | J Gastroenterol Hepatol | Role of the gut microbiota in human nutrition and metabolism. | 2013 | Details |
| A22860 | 24273273 | Nan Fang Yi Ke Da Xue Xue Bao | [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease]. | 2013 | Details |
| A22861 | 24269922 | Clin Gastroenterol Hepatol | Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin. | 2013 | Details |
| A22862 | 24269473 | J Hepatol | Perilipin discerns chronic from acute hepatocellular steatosis. | 2013 | Details |
| A22863 | 24268461 | Arch Gerontol Geriatr | Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD? | 2013 | Details |
| A22864 | 24268118 | J Cardiovasc Comput Tomogr | Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
| A22865 | 24267865 | Liver Int | Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. | 2013 | Details |
| A22866 | 24266919 | Med Clin North Am | When to consider liver transplant during the management of chronic liver disease. | 2013 | Details |
| A22867 | 24266914 | Med Clin North Am | Review of treatment options for nonalcoholic fatty liver disease. | 2013 | Details |
| A22868 | 24265809 | PLoS One | Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family. | 2013 | Details |
| A22869 | 24265237 | Compr Physiol | Steatosis in the liver. | 2013 | Details |
| A22870 | 24264333 | Chest | Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. | 2014 | Details |
| A22871 | 24264040 | Int J Mol Sci | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. | 2013 | Details |
| A22872 | 24263777 | Arq Bras Cardiol | Assessment of the relationship between non-alcoholic fatty liver disease and CAD using MSCT. | 2013 | Details |
| A22874 | 24262589 | Clin Nutr | Diets and nonalcoholic fatty liver disease: the good and the bad. | 2013 | Details |
| A22875 | 24262002 | Liver Int | The impact of gender and NASH on chronic kidney disease before and after liver transplantation. | 2013 | Details |
| A22876 | 24260182 | PLoS One | The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. | 2013 | Details |
| A22877 | 24259972 | World J Gastroenterol | Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? | 2013 | Details |
| A22878 | 24259964 | World J Gastroenterol | Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. | 2013 | Details |
| A22879 | 24259612 | Ann Pharmacother | Resistant nonalcoholic fatty liver disease amelioration with rosuvastatin and pioglitazone combination therapy in a patient with metabolic syndrome. | 2013 | Details |
| A22880 | 24258517 | Semin Immunopathol | CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A22881 | 24256559 | Liver Int | Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. | 2013 | Details |
| A22882 | 24256515 | Clin Endocrinol (Oxf) | Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2013 | Details |
| A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
| A22884 | 24254551 | Eur Rev Med Pharmacol Sci | Hepatic splenosis presenting as arterialised liver lesion in a patient with NASH. | 2013 | Details |
| A22885 | 24254368 | Hepatology | The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. | 2014 | Details |
| A22886 | 24253218 | Int J Mol Med | Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein. | 2013 | Details |
| A22887 | 24252302 | Biomark Res | Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. | 2013 | Details |
| A22888 | 24251213 | Indian J Endocrinol Metab | Correlation between liver fat content with dyslipidemia and Insulin resistance. | 2013 | Details |
| A22889 | 24250305 | Afr Health Sci | Weight reduction improves markers of hepatic function and insulin resistance in type-2 diabetic patients with non-alcoholic fatty liver. | 2013 | Details |
| A22890 | 24249968 | J Clin Biochem Nutr | Dmbt1 does not affect a Western style diet-induced liver damage in mice. | 2013 | Details |
| A22891 | 24249635 | FASEB J | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2013 | Details |
| A22892 | 24247899 | Transplantation | Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. | 2013 | Details |
| A22893 | 24246334 | Endocr Pract | Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome. | 2014 | Details |
| A22894 | 24239806 | Toxicol Lett | Intrauterine metabolic programming alteration increased susceptibility to non-alcoholic adult fatty liver disease in prenatal caffeine-exposed rat offspring. | 2013 | Details |
| A22896 | 24235062 | World J Pediatr | Type 2 diabetes mellitus in pediatrics: a new challenge. | 2013 | Details |
| A22897 | 24228201 | Adv Nutr | Hepatic fatty acid trafficking: multiple forks in the road. | 2013 | Details |
| A22898 | 24226095 | J Biol Chem | Retinoic acid-related orphan receptor α regulates diurnal rhythm and fasting induction of sterol 12α-hydroxylase in bile acid synthesis. | 2013 | Details |
| A22899 | 24224789 | Acta Physiol (Oxf) | Maternal western diet primes non-alcoholic fatty liver disease in adult mouse offspring. | 2014 | Details |
| A22900 | 24223115 | PLoS One | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. | 2013 | Details |
| A22901 | 24222948 | World J Gastroenterol | Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection. | 2013 | Details |
| A22902 | 24222944 | World J Gastroenterol | Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. | 2013 | Details |
| A22903 | 24222941 | World J Gastroenterol | PNPLA3 I148M polymorphism and progressive liver disease. | 2013 | Details |
| A22904 | 24222095 | Semin Liver Dis | Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. | 2013 | Details |
| A22905 | 24222094 | Semin Liver Dis | PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. | 2013 | Details |
| A22906 | 24222092 | Semin Liver Dis | The role of gastrointestinal hormones in hepatic lipid metabolism. | 2013 | Details |
| A22907 | 24222091 | Semin Liver Dis | Bile acid-mediated control of liver triglycerides. | 2013 | Details |
| A22908 | 24222090 | Semin Liver Dis | The unfolded protein response in fatty liver disease. | 2013 | Details |
| A22909 | 24222089 | Semin Liver Dis | The lipid droplet as a potential therapeutic target in NAFLD. | 2013 | Details |
| A22911 | 24219909 | Cell Signal | Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. | 2013 | Details |
| A22912 | 24219083 | J Gastroenterol Hepatol | Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes. | 2014 | Details |
| A22913 | 24219010 | J Gastroenterol Hepatol | Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. | 2014 | Details |
| A22914 | 24217942 | J Appl Toxicol | Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. | 2013 | Details |
| A22915 | 24215040 | Scott Med J | An epidemiological study of the association of coffee with chronic liver disease. | 2013 | Details |
| A22916 | 24214843 | Mol Nutr Food Res | Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. | 2013 | Details |
| A22917 | 24213605 | Int J Mol Sci | Environmental pollution: a tangible risk for NAFLD pathogenesis. | 2013 | Details |
| A22918 | 24211299 | Gastroenterology | Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. | 2013 | Details |
| A22919 | 24211274 | Toxicol Appl Pharmacol | CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. | 2013 | Details |
| A22920 | 24210820 | Cell Rep | SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. | 2013 | Details |
| A22921 | 24209497 | Lipids Health Dis | Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies. | 2013 | Details |
| A22922 | 24206739 | Arab J Gastroenterol | Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A22923 | 24206666 | Cell Metab | Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler. | 2013 | Details |
| A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
| A22925 | 24206433 | Aliment Pharmacol Ther | Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets. | 2013 | Details |
| A22926 | 24205731 | Nihon Rinsho | [An inhibitor of intestinal cholesterol transporter]. | 2013 | Details |
| A22927 | 24205725 | Nihon Rinsho | [Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides]. | 2013 | Details |
| A22928 | 24205128 | PLoS One | Liver glycerol permeability and aquaporin-9 are dysregulated in a murine model of Non-Alcoholic Fatty Liver Disease. | 2013 | Details |